Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q1 2024 Earnings Call Transcript April 29, 2024 Ekso Bionics Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Ekso Bionics’ First Quarter 2024 Financial Results Call. At this […]
Q1 2024 Ekso Bionics Holdings Inc Earnings Call
SAN RAFAEL, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2024. Recent Highlights and Accomplishments Received final payment determination for Medicare reimbursement from the Centers for Medicare & Medicaid Services (“CMS”) for Ekso Indego PersonalReported revenues of $3.8 mill